Title of the centre:
WHO Collaborating Centre for Surveillance, Epidemiology & Control of Influenza
Director / Head:
Dr Rebecca Kondor
Dr John Steel
Institution:
Influenza Division, National Center for Immunization and Other Respiratory Diseases
Centers for Disease Control and Prevention (CDC)
Address:
1600 Clifton Road, A-20
30333
Georgia
Town:
Atlanta
Country:
USA
Region:
AMRO
Phone:
(1-404) 639 3387
Fax:
(1-404) 639 2334
Date of Designation:
01/Jan/1956
Last Redesignation:
29/Apr/2022
Expiry:
29/Apr/2026
Date of Discontinuation:
Terms of Reference:
- In support to WHO, to maintain national & international virologic and disease surveillance for both seasonal and novel influenza and conduct thorough virus characterization and epidemiologic investigations.
- In support to WHO, to evaluate the impact and burden of disease for influenza.
- Upon WHO’s request, to conduct risk assessment studies for influenza viruses.
- In support to WHO, to evaluate the effectiveness of current seasonal influenza vaccines and develop new types of vaccines for protection against influenza.
- In support to WHO, to evaluate the effectiveness of and monitor the susceptibility of influenza viruses to antiviral drugs.
- To provide technical assistance and capacity building, including laboratory and epidemiologic training, to strengthen the WHO Global Influenza Surveillance and Response System (GISRS) as requested by WHO.
- Upon WHO’s request, to produce, and supply epidemic and pandemic vaccine reference strains, diagnostic reagents, virologic and immunologic tests to WHO GISRS and other institutions as agreed by WHO for the characterization and control of influenza.
- Under WHO’s leadership, contribute to the implementation of the WHO Pandemic Influenza Preparedness (PIP) Framework, respecting rules set out by the PIP Framework for sharing of influenza viruses and access to vaccines and other benefits (http://www.who.int/influenza/pip/en/Framework) and to work under the Terms of Reference related to the work with Pandemic Influenza Preparedness biological materials as described in Annex 5 of the PIP Framework Document.
-
-
Types of activity:
- Product development (guidelines; manual; methodologies; etc.)
- Outbreaks and emergencies
- Providing technical advice to WHO
WHO Outputs:
| |
2.2.2 - Proven prevention strategies for priority pandemic-/epidemic-prone diseases implemented at scale |
| |
2.2.3 - Mitigate the risk of the emergence and re-emergence of high-threat pathogens |
| |
2.2.1 - Research agendas, predictive models and innovative tools, products and interventions available for high-threat health hazards |
Responsible Officer:
ZHANG Wenqing
Phone:
+41 22 791 4282
Technical Counterpart:
VICARI Andrea Sebastiano
Phone:
Access to annual progress reports and the current workplan (this is accessible to WHO Staff Members only):
Link to eWork
|